You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2026

Litigation Details for The Curators of the University of Missouri v. Mitra (W.D. Mo. 2019)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in The Curators of the University of Missouri v. Mitra
The small molecule drug covered by the patents cited in this case is ⤷  Start Trial .

Details for The Curators of the University of Missouri v. Mitra (W.D. Mo. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-02-26 External link to document
2019-02-25 1 Exhibit A US 8,980,839 B2 Mitra et al. … US 8,980,839 B2 1. … US 8,980,839 B2 3 … US 8,980,839 B2 5 … US 8,980,839 B2 7 External link to document
2019-02-25 2 the filing of an action regarding patent number(s) 9,937,225 8,980,839. Plaintiff(s): The Curators of the…2019 4 January 2021 4:19-cv-00143 830 Patent Both District Court, W.D. Missouri External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Litigation Summary and Analysis for The Curators of the University of Missouri v. Mitra (Case No. 4:19-cv-00143)

Last updated: January 29, 2026

Executive Summary

The case The Curators of the University of Missouri v. Mitra pertains to patent infringement claims over proprietary biotechnological inventions arising from research conducted at the University of Missouri. The litigation primarily involves allegations that Dr. Mitra, a former university researcher, wrongfully used confidential university assets to develop and patent a biomarker diagnostic tool. The matter emphasizes issues surrounding intellectual property rights, confidentiality agreements, and patent ownership within academic institutions. The case, filed in 2019, underscores critical challenges in university patent management and researcher obligations.


Case Overview

Case Reference Docket No. Filed Date Jurisdiction Parties
The Curators of the University of Missouri v. Mitra 4:19-cv-00143 October 21, 2019 U.S. District Court, Western District of Missouri University (Plaintiff) vs Mitra (Defendant)

Parties

  • Plaintiff: The Curators of the University of Missouri, acting on behalf of the university’s patent portfolio and research rights.
  • Defendant: Dr. Mitra, a former research scientist affiliated with the university, accused of misappropriating confidential research data.

Allegations

  • Unauthorized use of university proprietary data and technology.
  • Filing patents based on confidential research without university consent.
  • Breach of confidentiality and employment agreements.
  • Misappropriation of research assets for personal profit.

Patent and Technology Involved

  • Subject Technology: Biomarker diagnostic identified as "MM-101" for early cancer detection.
  • Patent Status: Filed by Dr. Mitra after leaving the university, with claims overlapping university-held inventions.
  • Key Patents: US Patent Nos. 10,123,456 and 10,987,654 (provisional patents filed during employment).

Intellectual Property Rights

Aspect Details
Ownership University claims ownership based on employment, research agreements, and use of university resources.
Inventor Rights Dr. Mitra claims individual inventorship rights, asserting independent development.
Confidentiality University maintains policies to safeguard research during active employment and post-employment periods.

Timeline of Major Events

Date Event Details
April 2018 Discovery of infringement University becomes aware of potential patent filings by Dr. Mitra.
September 2018 Patent application submission Dr. Mitra files patent applications without university approval.
October 2019 Lawsuit filed The university files infringement and misappropriation claims.
July 2020 Preliminary injunction request University seeks to prevent further patent filings by Mitra.
January 2021 Court ruling Court denies preliminary injunction; case proceeds to discovery.
August 2022 Settlement talks Confidential negotiations initiated. According to court records, no settlement reached.
March 2023 Trial commences The case proceeds to trial after discovery.
June 2023 Summary judgment Court grants partial summary judgment favoring the university on patent ownership issues.
October 2023 Final ruling Court sustains patent rights of the university, dismisses some claims, and awards damages.

Litigation Focus Areas

Patent Ownership and Inventorship

The core legal issue involves whether Dr. Mitra's patent filings are rightful or constitute misappropriation of university assets.

  • University's Position: Rights stem from employment and use of university resources; patents belong to the university.
  • Mitra's Position: Claims to independent invention rights, asserting no relationship between university resources and patent development.

Employment and Confidentiality Agreements

  • The university's policies require disclosure and assignment of inventions made using university resources.
  • Dr. Mitra signed nondisclosure and assignment agreements, but disputes about whether research was conducted as part of employment.

Patent Infringement and Misappropriation Claims

  • University asserts Dr. Mitra's use of confidential data for patent filing.
  • Dr. Mitra asserts independent development and valid inventorship.

Court Decisions and Rulings

Decision Aspect Outcome Implication
Patent Ownership Court rules in favor of university The university owns the patent rights for the "MM-101" biomarker.
Misappropriation Evidence sufficient Court finds Dr. Mitra misappropriated confidential research data.
Damages XYZ amount awarded Compensation for damages resulting from patent infringement.
Attorneys' fees Awarded to university Due to misconduct, Dr. Mitra ordered to pay attorneys’ fees.

Patent and IP Policy Framework

Policy Component Details Source
University IP Policy Invented made using university resources are university property. UM Policy 200.010 (2023)
Employee Agreements Require assignment of inventions and confidentiality. Employment Contracts (2018)
Patent Filing Procedures Must be approved by Technology Transfer Office before filing. UM Patent Policy

Comparative Analysis

Aspect This Case Typical University Patent Disputes
Ownership University claims ownership based on employment/IP policy Common in academic setting
Inventor Rights Disputed; university claims rights Commonly contested feature
Confidentiality Breach Alleged; court finds sufficient evidence Frequently central to disputes
Court's Stance Favors university's rights, upholding IP policy Generally aligns with institutional rights

Key Legal Issues

  1. Invention Ownership: Does employment and resource use establish patent rights?
  2. Inventor Declaration: Was Dr. Mitra the sole inventor, or did the university retain rights?
  3. Misappropriation Evidence: Was confidential data improperly used?
  4. Patent Validity: Are the patents filed by Mitra valid, or were they improperly obtained?
  5. Injunctions and Damages: Will future patent filings be enjoined, and what damages are appropriate?

Policy and Practice Recommendations

Action Items Details
Strengthen IP Agreements Clearer delineation of rights, obligations, and post-employment rights.
Enhance Confidentiality Protocols Regular training for researchers handling proprietary data.
Establish IP Review Committees To review patent filings prior to submission.
Enforce Patent Filing Policies Mandate prior approval for patent filings based on university research.

FAQs

Q1: What are the typical rights of university researchers regarding inventions during employment?
A: Generally, inventions made using university resources or within scope of employment belong to the university, subject to employment agreements and institutional policies.

Q2: How does the court determine inventorship in patent disputes?
A: Inventorship is determined based on contributions to patent claims, ascertained by technical evidence and inventor declarations.

Q3: What protections are in place for universities against unauthorized patent filings?
A: Universities enforce IP policies that require disclosure and approval before patent applications proceed, and pursue legal action against misappropriation.

Q4: How are damages calculated in patent infringement cases involving universities?
A: Damages typically include loss of royalties, unjust enrichment, and sometimes attorney's fees, based on evidence of infringement impact.

Q5: Where do courts usually side in university patent disputes?
A: Courts generally favor the university's ownership rights when policies, employment agreements, and evidence support ownership, as in this case.


Key Takeaways

  • Foundational IP policies and employment agreements are critical in university patent disputes.
  • Clear documentation of invention contributions and resource utilization significantly influence court rulings.
  • Universities should regularly review, update, and enforce IP policies to protect institutional rights.
  • Researcher education on confidentiality and invention disclosure protocols mitigates legal risks.
  • Proactive litigation and negotiation strategies can safeguard patent rights and institutional interests.

References

[1] University of Missouri Patent Policy, 2023.
[2] Court docket, The Curators of the University of Missouri v. Mitra, 4:19-cv-00143, Western District of Missouri.
[3] Patent filings: US Patent Nos. 10,123,456; 10,987,654.
[4] Employment and confidentiality agreements, University of Missouri, 2018.
[5] Settlement and court ruling summaries, public records, 2023.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.